As AMR threatens to become the leading cause of death by 2050, vaccines could lead way to tackle drug-resistant infections and reduce reliance on antibiotics
Birmingham researchers hosted a unique event that brought together liver disease patients, researchers, charity partners, and an artist in residence.
The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
University of Birmingham and NHS England researchers have created a diagnostic code for presymptomatic type 1 diabetes to enhance healthcare treatment.
Professor Gary Middleton, Professor of Oncology, will be at the forefront of pioneering cancer research as ECMC Network Lead.
97% of patients who were deemed low risk and took part were assessed as not having allergy
University of Birmingham will lead UK-wide training to address critical skills demand in life sciences
The opportunity to eradicate a major and incurable bone marrow cancer has been made possible with a new programme funded by Cancer Research UK.
A Birmingham study reveals a novel cellular phenomenon could be responsible for the onset of primary biliary cholangitis (PBC).
First study tracking how NK cells respond in tumours found that stimulating the IL-15 pathway prevented the rapid loss of function and improved tumour control
Dr Shivan Sivakumar, a nationally recognised oncologist in cancers of the pancreas, liver and biliary tract, joins the College of Medical and Dental Sciences.
Dr Sally Clayton will study a novel pathway that becomes dysregulated in inflammatory diseases and how it controls the function in immune cells.